Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of 10 mg Alfuzosin Hydrochloride Prolonged-release Tablets under Fed Conditions in Healthy Thai Male Volunteers
TCTR20170217001Phase 4Completed
- Sponsor
- Research and Development
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of alfuzosin, sponsored by Research and Development. Started Jul 2017; status: completed.
02
Drugs
alfuzosin
Beyond the preview
Go deeper on TCTR20170217001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170217001.